Garner Asset Management Corp Astrazeneca PLC Transaction History

Garner Asset Management Corp

$212 Million
Q2 2024

A detailed history of Garner Asset Management Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Garner Asset Management Corp holds 3,496 shares of AZN stock, worth $248,740. This represents 0.13% of its overall portfolio holdings.

Number of Shares

3,496

Previous 3,556 1.69%

Holding current value

$248,740

Previous $241,000 13.28%

% of portfolio

0.13%

Previous 0.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$66.81 - $80.83 $4,008 - $4,849	-60 Reduced 1.69%	3,496 $273,000
Q1 2024 May 16, 2024	BUY	$61.03 - $69.57 $3,783 - $4,313	62 Added 1.77%	3,556 $241,000
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $42,085 - $47,110	-680 Reduced 16.29%	3,494 $235,000
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $25,875 - $28,608	-399 Reduced 8.73%	4,174 $283,000
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $103,117 - $111,819	-1,475 Reduced 24.39%	4,573 $327,000
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $21,344 - $24,200	-338 Reduced 5.29%	6,048 $420,000
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $3,252 - $4,226	-60 Reduced 0.93%	6,386 $433,000
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $42,097 - $107,785	-794 Reduced 10.97%	6,446 $354,000
Q2 2022 Jul 29, 2022	BUY	$59.26 - $71.14 $19,852 - $23,831	335 Added 4.85%	7,240 $478,000
Q4 2021 Jan 31, 2022	SELL	$54.02 - $63.83 $10,804 - $12,766	-200 Reduced 2.81%	6,905 $402,000
Q3 2021 Oct 29, 2021	SELL	$55.56 - $60.79 $1,111 - $1,215	-20 Reduced 0.28%	7,105 $427,000
Q1 2021 Apr 30, 2021	SELL	$47.16 - $54.44 $12,497 - $14,426	-265 Reduced 3.59%	7,125 $354,000
Q3 2020 Oct 30, 2020	SELL	$53.07 - $61.1 $26,535 - $30,550	-500 Reduced 6.34%	7,390 $405,000
Q1 2020 Apr 27, 2020	BUY	$37.79 - $51.33 $1,889 - $2,566	50 Added 0.64%	7,890 $352,000
Q2 2019 Jul 19, 2019	SELL	$37.28 - $41.68 $7,456 - $8,336	-200 Reduced 2.49%	7,840 $324,000
Q1 2019 Apr 23, 2019	SELL	$35.49 - $43.02 $19,519 - $23,661	-550 Reduced 6.4%	8,040 $325,000
Q3 2018 Oct 29, 2018	SELL	$34.76 - $39.72 $1,738 - $1,986	-50 Reduced 0.58%	8,590 $340,000
Q1 2018 Apr 27, 2018	SELL	$32.97 - $36.63 $17,968 - $19,963	-545 Reduced 5.93%	8,640 $0
Q4 2017 Jan 30, 2018	SELL	$32.09 - $34.78 $3,209 - $3,478	-100 Reduced 1.08%	9,185 $319,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,285	9,285 $317,000

Others Institutions Holding AZN

# of Institutions

1,341

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $220B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Garner Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Garner Asset Management Corp with notifications on news.

Account

Garner Asset Management Corp Astrazeneca PLC Transaction History